Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.98% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
United States Antimony
UAMY
$825M
| $1.72M | ﹤0.01% |
971,900
+228,000
| +31% | +$229K |
|
2152
Ascent Industries
ACNT
$136M
| $1.72M | ﹤0.01% |
153,500
+41,809
| +37% | +$430K |
|
2153
Cannae Holdings
CNNE
$635M
| $1.72M | ﹤0.01% |
86,400
-61,500
| -42% | -$1.23M |
|
2154
Krystal Biotech
KRYS
$9.83B
| $1.71M | ﹤0.01% |
10,900
-3,500
| -24% | -$621K |
|
2155
Monte Rosa Therapeutics
GLUE
$1.32B
| $1.71M | ﹤0.01% |
245,700
+27,000
| +12% | +$203K |
|
|
ENZ
2156
DELISTED
Enzo Biochem, Inc.
ENZ
| $1.69M | ﹤0.01% |
2,367,543
-159,986
| -6% | -$166K |
|
2157
Ocugen
OCGN
$458M
| $1.68M | ﹤0.01% |
+2,087,632
| New | +$1.91M |
|
2158
Corsair Gaming
CRSR
$1.41B
| $1.68M | ﹤0.01% |
253,736
-82,197
| -24% | -$571K |
|
2159
Manitowoc
MTW
$746M
| $1.67M | ﹤0.01% |
183,349
+24,600
| +15% | +$243K |
|
2160
Cerence
CRNC
$407M
| $1.67M | ﹤0.01% |
212,838
+21,438
| +11% | +$108K |
|
2161
Eagle Bancorp Montana
EBMT
$187M
| $1.67M | ﹤0.01% |
108,715
+20,812
| +24% | +$343K |
|
2162
Vanguard Financials ETF
VFH
$14B
| $1.66M | ﹤0.01% |
14,100
| – | – |
|
2163
iShares MSCI KLD 400 Social ETF
DSI
$5.58B
| $1.66M | ﹤0.01% |
15,100
+9,500
| +170% | +$1.06M |
|
2164
Mastech Digital
MHH
$94.7M
| $1.66M | ﹤0.01% |
111,727
+2,600
| +2% | +$32.3K |
|
2165
Delcath Systems
DCTH
$581M
| $1.66M | ﹤0.01% |
138,242
-173,558
| -56% | -$1.83M |
|
2166
Landmark Bancorp
LARK
$196M
| $1.66M | ﹤0.01% |
72,717
-4,745
| -6% | -$97.9K |
|
2167
Cameco
CCJ
$42.6B
| $1.66M | ﹤0.01% |
+32,300
| New | +$1.76M |
|
2168
MINISO
MNSO
$3.52B
| $1.66M | ﹤0.01% |
69,295
-252,800
| -78% | -$5.1M |
|
|
ASM
2169
Avino Silver & Gold Mines
ASM
$1.23B
| $1.65M | ﹤0.01% |
1,874,867
+1,485,910
| +382% | +$1.71M |
|
2170
Global X Copper Miners ETF NEW
COPX
$7.98B
| $1.65M | ﹤0.01% |
+43,200
| New | +$1.87M |
|
|
DADA
2171
DELISTED
Dada Nexus
DADA
| $1.65M | ﹤0.01% |
1,362,900
+232,100
| +21% | +$371K |
|
2172
Colony Bankcorp
CBAN
$473M
| $1.65M | ﹤0.01% |
102,170
-11,508
| -10% | -$188K |
|
|
ABX
2173
Abacus Global Management
ABX
$907M
| $1.65M | ﹤0.01% |
210,500
+164,334
| +356% | +$1.41M |
|
2174
Oportun Financial
OPRT
$355M
| $1.65M | ﹤0.01% |
424,600
+77,907
| +22% | +$251K |
|
|
VBNK
2175
VersaBank
VBNK
$658M
| $1.65M | ﹤0.01% |
118,800
+46,830
| +65% | +$719K |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.